Our half-yearly results, out this morning show good progress on exits with more in the pipeline; encouraging developments in our key portfolio companies and that maintaining our balance sheet strength remains a priority. Read more: https://bit.ly/47uVVeA Greg Smith, Chief Executive of IP Group plc, said: “The Group has made progress on delivering cash proceeds in the year to date, and has a strong pipeline of future realisations, some at an advanced stage of negotiation. We are seeing improvement in market sentiment toward private transactions in the areas in which we operate, which has been reflected in our ability to realise investments. Furthermore, we expect these exits to take place at or above their carrying values at the end of last year, validating our prudent approach to portfolio valuation. As a result, the Group remains in a strong financial position with £183.7m of gross cash at the end of August which is particularly important in the current environment. The Board remains committed to delivering shareholder returns that include a regular cash component from realisations. With a share price discount to NAV of more than 20%, we have not only accelerated our buyback programme in the period and have now bought back £20.0m of shares under our planned programme but also plan to increase it by an additional £10m. As the UK’s most active investor in university spinouts, we are pleased with the progress in our portfolio in our three thematic sectors, with our portfolio continuing to mature and attract commercial and strategic interest, and we continue to believe we remain well positioned to deliver good financial returns for our shareholders.” #VisionaryVentures
About us
IP Group accelerates the impact of science for a better future. As the most active UK based, early-stage science investor, we develop and support some of the world’s most exciting businesses in deeptech, life sciences and cleantech (led by Kiko Ventures). Through Parkwalk, the UK's largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, First Light Fusion, Hysata, and Oxbotica. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.
- Website
-
http://www.ipgroupplc.com
External link for IP Group plc
- Industry
- Financial Services
- Company size
- 51-200 employees
- Headquarters
- London, England
- Type
- Public Company
Locations
Employees at IP Group plc
Updates
-
Parkwalk Advisors, our specialist EIS fund manager, has just released its annual report on the UK spinout sector, and there are encouraging signs of recovery in the funding landscape. Life Sciences remain a key area of strength, with an impressive 210 deals completed between H2 2023 and H2 2024. Additionally, the global appeal of UK spinouts continues to rise, as foreign investor participation grows. We're proud that IP Group plc and Parkwalk Advisors are leading the way as the UK's top investor in spinouts, contributing to 40 deals over the past year. As the most active investor in UK science and technology, we see immense potential in these innovative companies to deliver strong returns and drive significant economic impact. Explore the full report below for more insights. https://lnkd.in/eND8QKFy #Parkwalk #investment
Today we launch our annual ‘Equity Investments into Spinouts’ 2024 report, in conjunction with Beauhurst. Download the report here: https://lnkd.in/eND8QKFy The report unpacks the funding landscape for businesses raising capital to pioneer breakthrough ideas from UK universities. The key findings include: 📣 UK spinout investment is expected to reach £2.3bn in 2024, signalling a funding recovery following a challenging year in 2023 📣 The Life Sciences sector continues to thrive with 210 deals for UK spinouts between H2 2023 and H1 2024 📣 The global appeal of UK spinouts is trending upwards with greater participation from foreign investors since 2021 📣 Parkwalk maintained its position as the leading investor in UK spinouts, participating in the most equity deals in 2023 At Parkwalk Advisors, we believe that the case for uncovering, nurturing and backing spinouts could not be stronger. It is critical that founders can access the long-term funding needed to grow and scale here in the UK, and encouragingly, this report shows that the green shoots of an investment recovery in spinouts has taken root. You can read the full report here: https://lnkd.in/e-MgTEHb The report findings are also featured in The Times article “Investment in university spin-outs revives after a tough period” which you can read here: https://lnkd.in/em6PYwED #EquityInvestmentintoSpinouts #EIS #spinouts #InvestinginInnovation
-
This week, IP Group CEO Greg Smith and Joyce Dan Xie, CFA, Managing Director, Global Capital were guest panellists at the British Private Equity & Venture Capital Association (BVCA) Summit in London. Greg discussed the scale of the multi-billion investment opportunity in venture and growth as well as the evolving investment models enabling pension schemes to do so, including those being pioneered by IP Group. Joyce was joined by industry peers, where they focused on the issue of the scale up gap in the UK and what policy measures can unlock greater capital. Thank you to everyone involved and to those who joined us for this gathering of the private capital industry. #privatecapital #innovation #scienceandtechnology #lifesciences
-
Next week on 11-12 September, IP Group plc’s CEO Greg Smith and Joyce Dan Xie, CFA, Managing Director, Global Capital, will be speaking at the British Private Equity & Venture Capital Association (BVCA) Summit - the UK’s largest conference for the private capital industry. Greg will join a fireside chat to discuss evolving investment models for pension schemes, including the scale of opportunity and some of the innovation already emerging. Joyce will take part in a panel session exploring how to best bridge the funding gap for scaling companies and the policy measures to unlock more capital. As one of the most active investors in university and research-based companies in the world which has been backed by British pension funds for years, we are living proof of why pensions can count on science. We know how important it is to get the conditions right for capital to flow into the country’s most innovative companies - and the extraordinary impact that can be achieved. We look forward to sharing our insights and working with industry leaders to support more UK success stories of the future. https://lnkd.in/dR6-g5P #privatecapital #innovation #scienceandtechnology #lifesciences
-
💡The latest edition of our newsletter is now available to read. Featuring news from the Group and portfolio companies including Oxford Nanopore Technologies, Intelligent Ultrasound and Enterprise Therapeutics. Read here: https://bit.ly/3z4aN6P To sign up to receive our newsletter go here: https://bit.ly/444qDHW #BackingInnovation
-
Exciting news today from IP Group Australia, who have invested into Forge Photonics, an autonomous vehicle navigation systems company aiming to disrupt the $A120 billion global market by dramatically reducing the cost of navigation systems for a range of markets including self-driving cars, marine vehicles, and defence. IP Group Principal Eeshan Kulkarni said: “We are excited by our investment in Forge Photonics, who are on their way to developing radically new architecture for navigation systems.” “Self-driving cars need to know where they are, otherwise they can crash and cause damage, injuries and death. Current navigation technology at a level that provides the desired degree of safety is uneconomical, and the solution developed by the Forge team can unlock the potential for widespread adoption.” Read more: https://bit.ly/4e3Otci
-
Great news today from portfolio company Microbiotica , which has announced it has received regulatory approvals in the EU and UK to initiate Phase 1b clinical studies for its live biotherapeutic products (LBPs) in advanced melanoma (MELODY-1: MB097) and ulcerative colitis (COMPOSER-1: MB310). Congratulations to the whole team on this huge milestone! Read more here: https://bit.ly/4e11tiS #biotech #melanoma #ulcerativecolitis
-
🛫 Congratulations to OXCCU TECH LTD - portfolio company within our cleantech platform Kiko Ventures - on opening its OX1 plant at Oxford Airport, a world-first demonstration plant converting CO2 and green hydrogen directly to jet fuel range hydrocarbons in a unique single-step process. This is an exciting milestone for the company on its journey to produce sustainable aviation fuel (#SAF) which will enable future generations the continued use of hydrocarbon fuels but without their climate impact. Read more below 👇
Today marks an exciting milestone for OXCCU! We’re proud to announce the opening of our OX1 plant at Oxford Airport, a world-first demonstration plant converting CO2 and green hydrogen directly to jet fuel range hydrocarbons in a unique single-step process. OX1 showcases British innovation at its best, developed through a decade of research at the University of Oxford and supported by both significant industry and government investment. This plant will set the stage for our larger OX2 plant at Saltend, helping us deliver cost-effective, scalable PtL SAF. We look forward to showing media and investors around over the coming days. Thanks to BusinessGreen for covering our news - https://lnkd.in/eQmmbFBp #SAF #PtL #Innovation #ClimateTech #OX1Plant
-
A great read from Nigel Toon – a leading figure in the UK semiconductor industry, who has made a great addition to the Board at portfolio company Intrinsic – in which he discusses the huge potential of Intrinsic’s Resistive-Random-Access-Memory (ReRAM) technology. IP Group plc are proud to have backed the company with seed and follow-on investment funding since 2020 and are excited to see Intrinsic continue to grow and excel.
New ReRAM memory technology opens up the potential to bring powerful AI to small consumer devices... Mark Dickinson Dave Grimm Dr Lee Thornton Owen Metters Adnan Mehonic Anthony Kenyon Intrinsic
AI coming soon to consumer devices...
Nigel Toon on LinkedIn
-
Delighted to announce that following strong performance on portfolio realisations during the year to date, cash proceeds from exits confirmed or completed now total over £43m, a level that already exceeds the total for the whole of 2023. As a result, the Directors plan to increase the Group’s current share buyback programme by a further £10m. This will increase the current programme to a total of £30m. Since this programme was announced in December 2023, the Group has bought back 29m shares, approximately 3% of the shares in issue, for a total of £13m. The Group will also announce its half-year results on 17 September and will hold a webinar at 9am that day. You can find out more here: https://bit.ly/4defxph